Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma

NCT03505944 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

59

Enrollment

NETWORK

Sponsor class

Conditions

Relapsed Non Hodgkin Lymphoma

Interventions

DRUG: Venetoclax

Sponsor

Nordic Lymphoma Group